Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antigenic changes associated with liver carcinogenesis

Journal of Toxicology and Environmental Health

|March 1, 1979

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comments on appendix C of the national institutes of health response to the petition of the american anti-vivisection society to prohibit the use of animals in the production of monoclonal antibodies.

Alternatives to laboratory animals : ATLA·2015

Same author

The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2005

Same author

Side population/ABCG2-positive cells represent a heterogeneous group of haemopoietic cells: implications for the use of adult stem cells in transplantation and plasticity protocols.

Bone marrow transplantation·2004

Same author

Targeted cytokine delivery to neuroblastoma.

Biochemical Society transactions·2002

Same author

Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1.

Clinical and experimental immunology·2001

Same author

Anti-8-oxo-2'-deoxyguanosine phage antibodies: isolation, characterization, and relationship to disease states.

Biochemical and biophysical research communications·2001

New antigens on carcinogen-induced liver tumors can trigger tumor immunity, offering potential immunotherapy targets. Reexpressed fetal antigens may serve as diagnostic markers for liver neoplasia.

Area of Science:

Hepatocellular carcinoma research
Tumor immunology
Cancer biomarker discovery

Background:

Carcinogen-induced liver tumors exhibit unique antigens.
These antigens arise from cell-carcinogen interactions.
Their role in immune surveillance is unclear but they are potential immunotherapy targets.

Purpose of the Study:

To investigate novel antigens in experimental hepatomas.
To explore the potential of these antigens in tumor immunotherapy and diagnosis.
To understand the role of antigens in liver carcinogenesis.

Main Methods:

Induction of experimental hepatomas in syngeneic hosts.
Characterization of tumor-specific antigens.
Analysis of fetal antigen expression (e.g., alpha 1-fetoprotein).

Related Experiment Videos

Main Results:

Individually distinct antigens capable of inducing tumor immunity were identified.
Reexpressed fetal antigens were detected on hepatoma cells and as secretory products.
Common antigens appeared early after carcinogen treatment, preceding malignant cell detection.

Conclusions:

Tumor-associated antigens offer promising targets for liver cancer immunotherapy.
Fetal antigens may serve as valuable diagnostic indicators for neoplastic changes.
Antigens associated with liver carcinogenesis are crucial for understanding neoplasia.